The global dental membrane and bone graft substitute market Growth Accelerated by Enhanced Demand for Dental Regenerative Treatments
Dental membranes and bone graft substitutes play a vital role in dental regenerative treatments by protecting implants and promoting bone regeneration during dental surgical procedures like dental implants and alveolar bone grafting. Membranes form protective barriers that direct new bone growth to replace damaged or resorbed bone. Bone graft substitutes provide scaffolding for regenerated bone to form and replace damaged bone.
The global dental
membrane and bone graft substitute market is estimated to be valued at US$
1,045.3 M in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast
period 2023 to 2030, as highlighted in a new report published by Coherent
Market Insights.
Market key trends:
The enhanced demand for dental regenerative treatments is one of the key trends
driving the growth of the dental membrane and bone graft substitute market.
With rising cases of dental injuries, periodontal diseases, and congenital
dental birth defects, the demand for associated surgical treatments like dental
implants, alveolar bone grafting, and sinus lift procedures has increased
significantly. As membranes and bone graft substitutes play a critical role in
maximizing the success rates of such dental regenerative surgeries, their
demand is also witnessing significant boost. Advanced membrane and bone graft
substitute products that result in faster healing and higher bone regeneration
are gaining more popularity among dental surgeons and patients alike due to
their therapeutic advantages. This growing preference for advanced substitutes
tailored for enhanced dental regeneration is expected to propel the market
growth over the forecast period.
Segment Analysis
The global dental membrane and bone graft substitute market is segmented by product, material, application, end-user, and region. The allograft sub-segment dominates the market under the product segment as they are derived from human tissue and have excellent biocompatibility. They promote bone regeneration and form a scaffold matrix to allow new bone formation. Since they contain human tissue, they pose a very low risk of disease transmission or immunogenic rejection as compared to xenografts and synthetic grafts.
Key Takeaways
Regional analysis
North America currently dominates the market due to the increasing geriatric population in countries like the United States which has greater propensity for dental issues. This has increased the demand for dental procedures like dental implants and bone grafts in the region. Additionally, favorable reimbursement policies for dental procedures, presence of major companies, and higher adoption of advanced dental technologies have accelerated market growth in North America.
Key players
The major players operating in the dental membrane and bone graft substitute market are Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., and Dentsply Sirona Inc. Geistlich Pharma AG is a leading player providing collagen membranes and bone graft substitutes for guided bone regeneration and ridge augmentation. Zimmer Biomet Holdings, Inc. offers a wide range of dental bone graft materials, membranes, and tissue regeneration products. Dentsply Sirona Inc. provides dental membranes, allografts, and xenografts for socket preservation and dental implant procedures.
Comments
Post a Comment